# Palynziq

NDC: 68135-673
Generic name: pegvaliase-pqpz
Labeler / Manufacturer: BioMarin Pharmaceutical Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20180524

FDA application: BLA761079

## Active ingredients

- PEGVALIASE: 20 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68135-673"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68135-673
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6dba844a-db02-44f8-8593-ce497ed9406c